Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 1;143(9):2628-2630.
doi: 10.1093/brain/awaa252.

Parkinson's disease progression in the substantia nigra: location, location, location

Affiliations
Comment

Parkinson's disease progression in the substantia nigra: location, location, location

David E Vaillancourt et al. Brain. .

Abstract

This scientific commentary refers to ‘Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease’, by Biondetti et al. (doi:10.1093/brain/awaa216

PubMed Disclaimer

Figures

Figure 1
Figure 1
Historical evidence for location-specific changes in substantia nigra in Parkinson's disease. (A) Topographical progression of Parkinson’s disease, adapted from Fearnley and Lees (1991). Neuronal loss in ventrolateral (VL), ventromedial (VM), dorsolateral (DL), dorsomedial (DM), and pars lateralis (PL) tiers of the substantia nigra in mild (+), moderate (++), and severe (+++) Parkinson’s disease. The greatest neuronal loss occurs early in the ventrolateral tier with progression towards ventromedial, dorsolateral, dorsomedial, and pars lateralis with greater disease severity. (B) One-year changes in free water in the posterior substantia nigra (SN) for controls and patients with Parkinson’s disease, adapted from Ofori et al. (2015b). (C) Four-year changes in free water in the anterior and posterior substantia nigra in de novo Parkinson’s disease. Free water maps show the spatiotemporal progression over 4 years (Burciu et al., 2017). (D) Longitudinal changes in free water in anterior and posterior substantia nigra in controls and advanced Parkinson’s disease with a 3-year follow-up period, adapted with permission from Guttuso et al. (2018). (E) Neuromelanin 1-year changes in healthy control subjects, early and progressing Parkinson’s disease (PD) showing spatiotemporal posterior-anterior progression within the substantia nigra, adapted from Biondetti et al. (2020).

Comment on

References

    1. Biondetti E, Gaurav R, Yahia-Cherif L, Mangone G, Pyatigorskaya N, Valabregue R, et al.Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease. Brain 2020; 143: 2757--70. - PubMed
    1. Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, et al.Progression marker of Parkinson's disease: a 4-year multi-site imaging study. Brain 2017; 140: 2183–92. - PMC - PubMed
    1. de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, et al.Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann Neurol 2011; 69: 803–10. - PubMed
    1. Fearnley JM, Lees AJ.. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283–301. - PubMed
    1. Febo M, Perez PD, Ceballos-Diaz C, Colon-Perez LM, Zeng H, Ofori E, et al.Diffusion magnetic resonance imaging-derived free water detects neurodegenerative pattern induced by interferon-gamma. Brain Struct Funct 2020; 225: 427–39. - PMC - PubMed